Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Shares Outstanding (Weighted Average): 2009-2021

Historic Shares Outstanding (Weighted Average) for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $58.6 million.

  • Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) rose 2.04% to $59.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $59.8 million, marking a year-over-year increase of 2.04%. This contributed to the annual value of $58.6 million for FY2021, which is 0.60% up from last year.
  • Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $58.6 million in FY2021, which was up 0.60% from $58.3 million recorded in FY2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) peaked at $58.6 million during FY2021, and registered a low of $37.0 million during FY2018.
  • For the 3-year period, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $51.4 million, with its median value being $58.3 million (2020).
  • In the last 5 years, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) fell by 6.92% in 2018 and then skyrocketed by 55.60% in 2020.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $39.8 million in 2017, then dropped by 6.92% to $37.0 million in 2018, then increased by 1.18% to $37.5 million in 2019, then skyrocketed by 55.60% to $58.3 million in 2020, then rose by 0.60% to $58.6 million in 2021.